BTG Plc - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for BTG Plc Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

BTG Plc. The Group's principal activity developing and commercialising life science technologies. The Group in-licenses, develops and commercialises pharmaceuticals and has a broad pipeline of development programme targeting neurological and other disorders including varicose veins. It acquires the rights to early-stage pharmaceuticals and other medical technologies from a global network of corporations, universities and research institutions. The drug development programme are in the field of oncology, ageing, neuroscience and drug repositioning. The Group's products are Varisolve, Misopess, Benefix, Campath, Infecton, Juvidex and Symadex.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report